Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - Inspire Medical Systems (INSP) reported revenue of $239.72 million for the quarter ended December 2024, marking a year-over-year increase of 24.5$239.62 million by 0.04% [1] - The company achieved an EPS of $1.15, significantly higher than the$0.49 reported a year ago, resulting in an EPS surprise of 55.41% compared to the consensus estimate of $0.74 [1] Financial Performance - Inspire's stock has returned -10% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.1% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3] Operational Metrics - Inspire opened 72 new U.S. Medical Centers, surpassing the average estimate of 59 by four analysts [4] - The total number of U.S. Medical Centers reached 1,435, slightly above the average estimate of 1,430 [4] - The company established 12 new U.S. sales territories, which is below the average estimate of 13 by three analysts [4] - The total number of U.S. sales territories stands at 335, marginally below the average estimate of 336 [4]